Bilateral optic neuritis attributed to Pembrolizumab: A case report

被引：1

作者：

Faulkner, Lucy G. ^{[1
,2
]}

Akala, Oyeyemi ^{[1
]}

Chauhan, Meera ^{[1
]}

Dulloo, Sean ^{[1
]}

机构：

[1] Univ Hosp Leicester NHS Trust, Dept Oncol, Leicester LE1 5WW, England

[2] Univ Leicester, Leicester Canc Res Ctr, Leicester LE2 7LX, England

来源：

CURRENT PROBLEMS IN CANCER: CASE REPORTS | 2024年 / 13卷

关键词：

Optic Neuritis; Pembrolizumab; Immunotherapy; Immune-related adverse events; Case Report;

D O I：

10.1016/j.cpccr.2023.100271

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Immunotherapy has revolutionised cancer treatment over the past decade and is now well established in the management of a range of cancer primaries, including non-small cell lung cancer. Pembrolizumab acts as a checkpoint inhibitor through programmed death protein 1 (PD-1) inhibition. However, the use of immune checkpoint inhibitors can be complicated by immune-related adverse events (irAE). Neurological complications are rare but are associated with high morbidity compared to other irAE. Here we report a rare case of bilateral optic neuritis following Pembrolizumab in a patient treated for metastatic lung adenocarcinoma. The patient had also received whole brain radiotherapy during the course of the treatment. Symptom onset occurred during maintenance treatment and at twelve months after first commencing systemic anticancer treatment. Fundoscopy demonstrated optic disc pallor with enhancement of the optic nerves and optic chiasm was seen on Magnetic Resonance Imaging. Symptoms were refractory to steroid treatment and resulted in chronic and profound visual impairment.

引用

页数：6

共 22 条

[1] Radiation-Induced Optic Neuropathy: Literature Review [J].

Ataides, Fabricio Gomes ;

Silva, Samuel Flavio Braga Reis ;

Baldin, Julianna Joanna Carvalho Moraes De Campos .

NEURO-OPHTHALMOLOGY, 2021, 45 (03) :172-180

[2] Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment [J].

Bennett, Jeffrey L. ;

Costello, Fiona ;

Chen, John J. ;

Petzold, Axel ;

Biousse, Valerie ;

Newman, Nancy J. ;

Galetta, Steven L. .

LANCET NEUROLOGY, 2023, 22 (01) :89-100

[3] Factors Associated with Occurrence of Radiation-induced Optic Neuropathy at "Safe" Radiation Dosage [J].

Doroslovacki, Pavle ;

Tamhankar, Madhura A. ;

Liu, Grant T. ;

Shindler, Kenneth S. ;

Ying, Gui-Shuang ;

Alonso-Basanta, Michelle .

SEMINARS IN OPHTHALMOLOGY, 2018, 33 (04) :581-588

[4] Association of Immune Checkpoint Inhibitors With Neurologic Adverse Events A Systematic Review and Meta-analysis [J].

Farooq, Muhammad Zain ;

Aqeel, Sheeba Ba ;

Lingamaneni, Prasanth ;

Pichardo, Rayli Carolina ;

Jawed, Aleeza ;

Khalid, Saad ;

Banskota, Shristi Upadhyay ;

Fu, Pingfu ;

Mangla, Ankit .

JAMA NETWORK OPEN, 2022, 5 (04)

[5]

Francis JH, 2020, OPHTHALMOLOGY, V127, P1585, DOI 10.1016/j.ophtha.2020.05.003

[6] Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer [J].

Gandhi, L. ;

Rodriguez-Abreu, D. ;

Gadgeel, S. ;

Esteban, E. ;

Felip, E. ;

De Angelis, F. ;

Domine, M. ;

Clingan, P. ;

Hochmair, M. J. ;

Powell, S. F. ;

Cheng, S. Y. -S. ;

Bischoff, H. G. ;

Peled, N. ;

Grossi, F. ;

Jennens, R. R. ;

Reck, M. ;

Hui, R. ;

Garon, E. B. ;

Boyer, M. ;

Rubio-Viqueira, B. ;

Novello, S. ;

Kurata, T. ;

Gray, J. E. ;

Vida, J. ;

Wei, Z. ;

Yang, J. ;

Raftopoulos, H. ;

Pietanza, M. C. ;

Garassino, M. C. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (22) :2078-2092

[7] Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors [J].

Guidon, Amanda C. ;

Burton, Leeann B. ;

Chwalisz, Bart K. ;

Hillis, James ;

Schaller, Teilo H. ;

Amato, Anthony A. ;

Warner, Allison Betof ;

Brastianos, Priscilla K. ;

Cho, Tracey A. ;

Clardy, Stacey L. ;

Cohen, Justine, V ;

Dietrich, Jorg ;

Dougan, Michael ;

Doughty, Christopher T. ;

Dubey, Divyanshu ;

Gelfand, Jeffrey M. ;

Guptill, Jeffrey T. ;

Johnson, Douglas B. ;

Juel, Vern C. ;

Kadish, Robert ;

Kolb, Noah ;

LeBoeuf, Nicole R. ;

Linnoila, Jenny ;

Mammen, Andrew L. ;

Martinez-Lage, Maria ;

Mooradian, Meghan J. ;

Naidoo, Jarushka ;

Neilan, Tomas G. ;

Reardon, David A. ;

Rubin, Krista M. ;

Santomasso, Bianca D. ;

Sullivan, Ryan J. ;

Wang, Nancy ;

Woodman, Karin ;

Zubiri, Leyre ;

Louv, William C. ;

Reynolds, Kerry L. .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (07)

[8] Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up [J].

Haanen, J. ;

Obeid, M. ;

Spain, L. ;

Carbonnel, F. ;

Wang, Y. ;

Robert, C. ;

Lyon, A. R. ;

Wick, W. ;

Kostine, M. ;

Peters, S. ;

Jordan, K. ;

Larkin, J. .

ANNALS OF ONCOLOGY, 2022, 33 (12) :1217-1238

[9] Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study [J].

Johnson, Douglas B. ;

Manouchehri, Ali ;

Haugh, Alexandra M. ;

Quach, Henry T. ;

Balko, Justin M. ;

Lebrun-Vignes, Benedicte ;

Mammen, Andrew ;

Moslehi, Javid J. ;

Salem, Joe-Elie .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7

[10] Retrobulbar Optic Neuritis Induced by Pembrolizumab in a Patient with Lung Adenocarcinoma [J].

Kawakado, Keita ;

Tamura, Tomoki ;

Nakanishi, Masamoto ;

Makimoto, Go ;

Kuyama, Shoichi .

INTERNAL MEDICINE, 2021, 60 (24) :3941-3945

← 1 2 3 →